{"id":348,"date":"2009-10-27T13:00:00","date_gmt":"2009-10-27T13:00:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=nolato-nine-month-interim-report-strong-growth-for-nolato-telecom-efficiency-improvement-produce-intended-results"},"modified":"2009-10-27T13:00:00","modified_gmt":"2009-10-27T13:00:00","slug":"nolato-nine-month-interim-report-strong-growth-for-nolato-telecom-efficiency-improvement-produce-intended-results","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/fr\/mfn_news\/nolato-nine-month-interim-report-strong-growth-for-nolato-telecom-efficiency-improvement-produce-intended-results\/","title":{"rendered":"Nolato nine-month interim report: Strong growth for Nolato Telecom. Efficiency improvement produce intended results"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<pre><p>In today\u2019s nine-month interim report, Nolato has reported sales for the third quarter of SEK 653 million, representing a 6% drop compared with the same period last year, but a 17% increase compared with the second quarter of this year. Operating income (EBITA) was SEK 48 million, compared with SEK 64 million for the third quarter of 2008, while the EBITA margin was 7.4% (9.2%).\n\n\u201cCompared with the second quarter of this year, we have seen a general improvement,\u201d explains Hans Porat, President and CEO of Nolato. \u201cNolato Telecom in particular has experienced strong growth, with an increase in sales of almost 70%. This is in line with previously-announced information, with new product start-ups running as planned.\n\n\u201cNolato Telecom\u2019s strong growth has led to a greater need for working capital. We have also invested actively in both Nolato Medical and Nolato Telecom, and this has had an impact on cash flow, which stood at SEK -31 million (78).\u201d\n\nCompared with the strong third quarter of 2008, Nolato Telecom\u2019s sales fell 3% to SEK 309 million (318). Operating income (EBITA) was SEK 24 million (35).\n\nNolato Medical\u2019s sales rose by 2% to SEK 159 million (156). Operating income (EBITA) was unchanged compared with the same period last year, at SEK 20 million.\n\n\u201cDuring the quarter, Nolato Medical\u2019s volumes were affected by greater summer holiday effects than is normally the case,\u201d says Hans Porat. \u201cThe business area\u2019s focus on stronger project management and technical resources is continuing according to plan.\u201d\n\nNolato Industrial\u2019s sales totalled SEK 185 million (219), with operating income (EBITA) of SEK 9 million (15).\n\n\u201cThe efficiency improvement measures carried out at Nolato Industrial had their intended effect during the quarter, with earnings rising by SEK 16 million compared with the second quarter. Volumes have stabilised at a low level for most of our customer segments, although our customers\u2019 lead-time remains short-term.\u201d\n\nThe Group\u2019s sales for the first nine months of 2009 totalled SEK 1,816 million, representing a reduction of 13% compared with the same period in 2008. Operating income (EBITA) was SEK 103 million (184). The cash flow stood at SEK 60 million (144), with net debt of SEK 120 million (250).<\/p><\/pre>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In today\u2019s nine-month interim report, Nolato has reported sales for the third quarter of SEK 653 million, representing a 6% drop compared with the same period last year, but a 17% increase compared with the second quarter of this year. Operating income (EBITA) was SEK 48 million, compared with SEK 64 million for the third&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/fr\/mfn_news\/nolato-nine-month-interim-report-strong-growth-for-nolato-telecom-efficiency-improvement-produce-intended-results\/\">Continue reading <span class=\"screen-reader-text\">Nolato nine-month interim report: Strong growth for Nolato Telecom. Efficiency improvement produce intended results<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-348","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-report-interim-q3","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"fr","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/mfn_news\/348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/media?parent=348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}